Syngene International Share PriceSyngene International

₹770.6
-7.05 (-0.91%)
As on 22 September, 2023 | 14:49 BSE: 539268 NSE: SYNGENEISIN: INE398R01022

Syngene International Performance

Day Range

  • Low 762.95
  • High 785.5
770.6

52 Week Range

  • Low 535.1
  • High 860.25
770.6
  • Open Price773
  • Previous Close777.65
  • Volume823395

Start SIP in Syngene International

Start SIP

Syngene International Share Price

  • Over 1 Month -4.39%
  • Over 3 Month 3.99%
  • Over 6 Month 33.98%
  • Over 1 Year 37.39%

Syngene International Key Statistics

P/E Ratio 64
PEG Ratio 2.7
Market Cap Cr 30,979
Price to Book Ratio 8.6
EPS 11.7
Dividend 0.1
Relative Strength Index 39.27
Money Flow Index 63.48
MACD Signal 7.93
Average True Range 23.56

Syngene International Investment Rating

  • Master Rating:
  • Syngene Inter has an operating revenue of Rs. 3,356.50 Cr. on a trailing 12-month basis. An annual revenue growth of 23% is outstanding, Pre-tax margin of 19% is great, ROE of 12% is good. The company has a reasonable debt to equity of 14%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its 50DMA and around 15% up from its 200DMA. It needs to take out the 50DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 82 which is a GOOD score indicating consistency in earnings, a RS Rating of 63 which is FAIR indicating the recent price performance, Buyer Demand at B- which is evident from recent demand for the stock, Group Rank of 92 indicates it belongs to a poor industry group of Medical-Research Eqp/Svc and a Master Score of B is close to being the best. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Syngene International Financials
IndicatorJun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 716994787768645759
Operating Expenses Qtr Cr 552678556552473509
Operating Profit Qtr Cr 163316230216172249
Depreciation Qtr Cr 898895908680
Interest Qtr Cr 610141296
Tax Qtr Cr 165230281931
Net Profit Qtr Cr 7518911010273147
IndicatorMar 2023Mar 2022
Total Revenue Annual Cr 3,2642,654
Operating Expenses Annual Cr 2,2591,808
Operating Profit Annual in Cr 934793
Depreciation Cr 359310
Interest Annual Cr 4524
Tax Annual Cr 12888
Net Profit Annual Cr 473394
IndicatorMar 2023Mar 2022
Cash from Operating Activity Annual Cr 838582
Cash from Investing Activity Annual Cr -688-612
Cash from Financing Annual Activity Cr -340-31
Net Cash Flow Annual Cr -190-61
IndicatorMar 2023Mar 2022
Total ShareHolders Funds Annual Cr 3,6193,292
Fixed Assets Annual Cr 2,3862,739
Total Non Current Assets Annual Cr 2,9643,357
Total Current Assets Annual Cr 2,8842,204
Total Assets Annual Cr 5,8485,561
IndicatorMar 2023Mar 2022
Book Value Per Share Annual Rs 9082
ROE Annual % 1312
ROCE Annual % 1412
Total Debt to Total Equity Annual --
EBDIT Annual Margin % 3133
IndicatorJun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 808994786768645758
Operating Expenses Qtr Cr 596680555552472508
Operating Profit Qtr Cr 212314231217173250
Depreciation Qtr Cr 1029695908680
Interest Qtr Cr 1110141296
Tax Qtr Cr 305230281931
Net Profit Qtr Cr 9317911010274148
IndicatorMar 2023Mar 2022
Total Revenue Annual Cr 3,2642,657
Operating Expenses Annual Cr 2,2591,808
Operating Profit Annual in Cr 934796
Depreciation Cr 367310
Interest Annual Cr 4524
Tax Annual Cr 12989
Net Profit Annual Cr 464396
IndicatorMar 2023Mar 2022
Cash from Operating Activity Annual Cr 824581
Cash from Investing Activity Annual Cr -656-612
Cash from Financing Annual Activity Cr -343-31
Net Cash Flow Annual Cr -175-62
IndicatorMar 2023Mar 2022
Total ShareHolders Funds Annual Cr 3,6183,298
Fixed Assets Annual Cr 2,8442,739
Total Non Current Assets Annual Cr 3,4063,358
Total Current Assets Annual Cr 2,4252,206
Total Assets Annual Cr 5,8315,564
IndicatorMar 2023Mar 2022
Book Value Per Share Annual Rs 9082
ROE Annual % 1312
ROCE Annual % 1412
Total Debt to Total Equity Annual --
EBDIT Annual Margin % 3133

Syngene International Technicals

EMA & SMA

Current Price
₹770.6
-7.05 (-0.91%)
  • Bullish Moving Average
  • ___
  • 5
  • Bearish Moving Average
  • ___
  • 11
  • 20 Day
  • ₹809.53
  • 50 Day
  • ₹793.54
  • 100 Day
  • ₹757.63
  • 200 Day
  • ₹705.31
  • 20 Day
  • ₹805.38
  • 50 Day
  • ₹799.9
  • 100 Day
  • ₹762.29
  • 200 Day
  • ₹675.13

Syngene International Resistance and Support

PIVOT
₹787.05
Resistance
First Resistance ₹798.9
Second Resistance ₹820.15
Third Resistance ₹832
RSI 39.28
MFI 63.48
MACD Single Line 7.93
MACD 3.49
Support
First Resistance ₹765.8
Second Resistance ₹753.95
Third Resistance ₹732.7

Syngene International Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 1,464,061 93,275,326 63.71
Week 1,707,203 102,278,547 59.91
1 Month 971,071 52,369,882 53.93
6 Month 714,832 35,184,025 49.22

Syngene International Result Highlights

Syngene International Synopsis

NSE-Medical-Research Eqp/Svc

Syngene Internationa is involved in the business activities of Scientific research and development. Company’s Total Operating Revenue is Rs. 3193.50 Cr. and Equity Capital is Rs. 401.40 Cr. for the Year ended 31/03/2023. Syngene International Ltd. is a Public Limited Listed company incorporated on 18/11/1993 and has its registered office in the State of Karnataka, India. Company’s Corporate Identification Number(CIN) is L85110KA1993PLC014937 and registration number is 014937.
Market Cap 31,263
Sales 3,265
Shares in Float 18.09
No of funds 315
Yield 0.06
Book Value 8.63
U/D Vol ratio 1.4
LTDebt / Equity 14
Alpha 0.09
Beta 0.51

Syngene International

Owner NameJun-23Mar-23Dec-22Sep-22
Promoters 54.8%54.88%64.86%64.86%
Mutual Funds 8.58%8.35%5.01%4.78%
Insurance Companies 0.85%0.56%0.32%0.17%
Foreign Portfolio Investors 23.19%23.31%16.87%16.79%
Financial Institutions/ Banks 0.01%
Individual Investors 8.11%8.4%8.57%8.82%
Others 4.47%4.5%4.37%4.57%

Syngene International Management

Name Designation
Ms. Kiran Mazumdar Shaw Non Executive Chairman
Mr. Jonathan Hunt Managing Director & CEO
Prof. Catherine Rosenberg Non Executive Director
Ms. Vinita Bali Lead Independent Director
Dr. Vijay Kuchroo Independent Director
Dr. Carl Decicco Independent Director
Ms. Sharmila Abhay Karve Independent Director
Dr. Kush Parmar Independent Director
Mr. Paul Blackburn Independent Director

Syngene International Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Syngene International Corporate Action

Date Purpose Remarks
2023-07-26 Quarterly Results
2023-04-26 Audited Results & Final Dividend
2023-01-23 Quarterly Results
2022-10-19 Quarterly Results
2022-07-20 Quarterly Results
Date Purpose Remarks
2023-06-30 FINAL Rs.0.50 per share(5%)Final Dividend
2022-07-01 FINAL Rs.0.50 per share(5%)Final Dividend
2022-07-01 SPECIAL Rs.0.50 per share(5%)Special Dividend

Syngene International MF Shareholding

Name Amount(cr)
HDFC Balanced Advantage Fund Growth 61599
Kotak Equity Arbitrage Fund Growth 25860
UTI Flexi Cap Fund Regular Plan Growth 25612
SBI Arbitrage Opportunities Fund Regular Growth 17701
ICICI Prudential Equity Arbitrage Fund Regular Growth 12496
  • Company Name
  • CMP
  • Chg(%)
  • Company Name
  • CMP
  • Chg(%)

Syngene International FAQs

What is Share Price of Syngene International ?

Syngene International share price is ₹770 As on 22 September, 2023 | 14:35

What is the Market Cap of Syngene International ?

The Market Cap of Syngene International is ₹30979.3 Cr As on 22 September, 2023 | 14:35

What is the P/E ratio of Syngene International ?

The P/E ratio of Syngene International is 64 As on 22 September, 2023 | 14:35

What is the PB ratio of Syngene International ?

The PB ratio of Syngene International is 8.6 As on 22 September, 2023 | 14:35

Q2FY23